GL1X · GenesisL1 explorer

MolNFT v1 · #24160 · protein

Alpha-thrombin (hirugen) complexed with na-(N,N-dimethylcarbamoyl)- alpha-azalysine

1UMA: “Alpha-thrombin (hirugen) complexed with na-(N,N-dimethylcarbamoyl)- alpha-azalysine”. X-ray diffraction, 2 ligands (IN2, NAG), 1 pocket (best druggability 0.56). MolNFT v1 #24160 on GenesisL1: 3D structure, binding sites and pockets…

PDB
1UMA
Type
protein
Length
299 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Alpha-thrombin; Hirudin I
EC
3.4.21.5
UniProt
P00734, P28501
Ligands
IN2, NAG
Pockets
1 · best druggability 0.56

Structure

x-ray diffraction · 3 distinct chains · 17% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
LAlpha-thrombin (EC 3.4.21.5)protein3628% helix, 6% strandP00734
HAlpha-thrombin (EC 3.4.21.5)protein25315% helix, 35% strandP00734
IHirudin Iprotein1030% helix, 0% strandP28501

Ligands and binding sites

  • IN2 · N,N-dimethylcarbamoyl-alpha-azalysine · ligand · 2 copies · chains H
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · chains H

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13170.560.7642IN2

Interfaces

2 interfaces between chains.

  • L–H · 1488 Ų buried · 37 hydrogen bonds · protein-protein
  • H–I · 640 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide, 1 covalent, 1 glycan, 1 modified (disulfide, covalent ligand, N-glycosylation, sulfation).

Compared structures

  • 1UMA · Alpha-thrombin (hirugen) complexed with na-(N,N-dimethylcarbamoyl)-alpha-azalysine · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.